Analysing the immune response and optimising the effectiveness of Mesothelin CAR T-cell therapy in cancer. [ 2019 - ]

Research Grant

Brief description Chimeric Antigen Receptor (CAR) T-cells have engineered receptors attached to patient immune cells. They target cancer with less risk of damage to healthy cells. Our laboratory manufactures CAR T-cells targeting a tumour marker- mesothelin, found on pancreatic and other cancers. I plan to test these CAR T-cells in vitro and in mice followed by enrolling cancer patients in a clinical trial of CAR T-cells. My aim is to monitor safety, efficacy and help improve patient survival and quality of life.

Funding Amount $92,746.00

Funding Scheme Postgraduate Scholarships

Notes Medical/Dental Postgraduate Scholarship